{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T10:54:57Z","timestamp":1765191297333,"version":"3.46.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,8]]},"DOI":"10.7759\/cureus.98689","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T10:51:07Z","timestamp":1765191067000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Atypical Acute Encephalopathy Unmasking IgA Multiple Myeloma"],"prefix":"10.7759","author":[{"given":"Jamie T","family":"Abad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasnim","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renieh","family":"Nabaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunj","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Sturla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan AJ","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, et al.. Diagnosis and management of multiple myeloma: a review. J Am Med Assoc. 2022, 327:464-77. 10.1001\/jama.2022.0003","journal-title":"J Am Med Assoc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2005.01.024","article-title":"Neurological aspects of multiple myeloma and related disorders","volume":"18","author":"Dispenzieri A","year":"2005","unstructured":"Dispenzieri A, Kyle RA. Neurological aspects of multiple myeloma and related disorders. Best Pract Res Clin Haematol. 2005, 18:673-88. 10.1016\/j.beha.2005.01.024","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-44554","article-title":"Hyperviscosity syndrome in plasma cell dyscrasias","volume":"29","author":"Mehta J","year":"2003","unstructured":"Mehta J, Singhal S. Hyperviscosity syndrome in plasma cell dyscrasias. Semin Thromb Hemost. 2003, 29:467-71. 10.1055\/s-2003-44554","journal-title":"Semin Thromb Hemost"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1370132","article-title":"Hyperammonemic encephalopathy in multiple myeloma","volume":"139","author":"Oestmann A","year":"2014","unstructured":"Oestmann A, Aujesky D. Hyperammonemic encephalopathy in multiple myeloma. Dtsch Med Wochenschr. 2014, 139:1518-20. 10.1055\/s-0034-1370132","journal-title":"Dtsch Med Wochenschr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.07.014","article-title":"Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortality","volume":"37","author":"Pham A","year":"2013","unstructured":"Pham A, Reagan JL, Castillo JJ. Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortality. Leuk Res. 2013, 37:1229-32. 10.1016\/j.leukres.2013.07.014","journal-title":"Leuk Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-8652(199801)57:1<77::aid-ajh14>3.0.co;2-6","article-title":"Multiple myeloma associated with serum amino acid disturbance and high output cardiac failure","volume":"57","author":"Kuribayashi N","year":"1998","unstructured":"Kuribayashi N, Matsuzaki H, Hata H, et al.. Multiple myeloma associated with serum amino acid disturbance and high output cardiac failure. Am J Hematol. 1998, 57:1-77. 10.1002\/(sici)1096-8652(199801)57:1&lt;77::aid-ajh14&gt;3.0.co;2-6","journal-title":"Am J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108568","article-title":"Paraproteinemia: blood hyperviscosity and clinical manifestations","volume":"58","author":"McGrath MA","year":"1976","unstructured":"McGrath MA, Penny R. Paraproteinemia: blood hyperviscosity and clinical manifestations. J Clin Invest. 1976, 58:1155-62. 10.1172\/JCI108568","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/10428190902741489","article-title":"Development of hyperammonemic encephalopathy in patients with multiple myeloma may be associated with the appearance of peripheral blood myeloma cells","volume":"50","author":"Ikewaki J","year":"2009","unstructured":"Ikewaki J, Ogata M, Imamura T, Kohno K, Nakayama T, Kadota J. Development of hyperammonemic encephalopathy in patients with multiple myeloma may be associated with the appearance of peripheral blood myeloma cells. Leuk Lymphoma. 2009, 50:667-9. 10.1080\/10428190902741489","journal-title":"Leuk Lymphoma"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.518654","article-title":"Bortezomib, cyclophosphamide, and dexamethasone: highly effective for rapid reversal of myeloma-associated hyperammonemic encephalopathy","volume":"51","author":"Howman R","year":"2010","unstructured":"Howman R, Thakerer A, Pitman M, Ding N, Thompson PA, Khot A, Harrison SJ. Bortezomib, cyclophosphamide, and dexamethasone: highly effective for rapid reversal of myeloma-associated hyperammonemic encephalopathy. Leuk Lymphoma. 2010, 51:2299-302. 10.3109\/10428194.2010.518654","journal-title":"Leuk Lymphoma"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401077","article-title":"In vitro excess ammonia production in human myeloma cell lines","volume":"12","author":"Otsuki T","year":"1998","unstructured":"Otsuki T, Yamada O, Sakaguchi H, et al.. In vitro excess ammonia production in human myeloma cell lines. Leukemia. 1998, 12:1149-58. 10.1038\/sj.leu.2401077","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0010-22","article-title":"Multiple myeloma with hyperammonemia treated with novel agents: a case series of three patients","volume":"62","author":"Nakamura H","year":"2023","unstructured":"Nakamura H, Takada K, Murase K, Ikeda H, Iyama S, Manabe T, Kobune M. Multiple myeloma with hyperammonemia treated with novel agents: a case series of three patients. Intern Med. 2023, 62:775-8. 10.2169\/internalmedicine.0010-22","journal-title":"Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-016-2730-7","article-title":"Steroid-responsive hyperammonemic encephalopathy as first manifestation of multiple myeloma","volume":"38","author":"Gaiani A","year":"2017","unstructured":"Gaiani A, Pompanin S, Zambello R, Briani C, Cagnin A. Steroid-responsive hyperammonemic encephalopathy as first manifestation of multiple myeloma. Neurol Sci. 2017, 38:503-5. 10.1007\/s10072-016-2730-7","journal-title":"Neurol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/394596-a-case-of-atypical-acute-encephalopathy-unmasking-iga-multiple-myeloma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T10:51:07Z","timestamp":1765191067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/394596-a-case-of-atypical-acute-encephalopathy-unmasking-iga-multiple-myeloma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.98689","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,8]]}}}